Related Experiment Video
Updated: Jun 24, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Blood group antigen recognition by a solute-binding protein from a serotype 3 strain of Streptococcus pneumoniae
Melanie A Higgins1, D Wade Abbott, Martin J Boulanger
1Biochemistry and Microbiology, University of Victoria, PO Box 3055, STN CSC, Victoria, BC, Canada V8W 3P6.
Abstract:
Streptococcus pneumoniae is a common bacterial pathogen that is well known for its ability to cause acute respiratory disease (pneumonia), ear infections, and other serious illnesses. This Gram-positive bacterium relies on its carbohydrate-metabolizing capabilities for full virulence in its host; however, the range of glycan targets that it can attack is presently not fully appreciated. S. pneumoniae is known to have a fucose utilization operon that in the TIGR4 strain plays a role in its virulence. Here we identify a second type of fucose utilization operon that is present in a subset of S. pneumoniae strains, including the serotype 3 strain SP3-BS71. This operon contains a transporter with a solute-binding protein, FcsSBP (fucose solute-binding protein), that interacts tightly (Ka approximately 1 x 10(6) M(-1)) and specifically with soluble A- and B-antigen trisaccharides but displays no selectivity between these two sugars. The structure of the FcsSBP in complex with the A-trisaccharide antigen, determined to 2.35 A, reveals its mode of binding to the reducing end of this sugar, thus highlighting this protein's requirement for soluble blood group antigen ligands. Overall, this report exposes a heretofore unknown capability of certain S. pneumoniae strains to transport and potentially metabolize the histo-blood group antigen carbohydrates of its host.
Insights
Certain Streptococcus pneumoniae strains possess a novel fucose utilization operon. This allows them to transport and metabolize host histo-blood group antigens, impacting bacterial virulence.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Streptococcus pneumoniae causes significant human diseases like pneumonia.
- Bacterial virulence is linked to carbohydrate metabolism, but S. pneumoniae's glycan targets are not fully understood.
- A known fucose utilization operon contributes to virulence in some S. pneumoniae strains.
Purpose of the Study:
- To identify and characterize novel carbohydrate utilization pathways in S. pneumoniae.
- To investigate the role of fucose metabolism in S. pneumoniae virulence.
- To understand the molecular basis of S. pneumoniae's interaction with host glycans.
Main Methods:
- Genomic analysis to identify new operons.
- Protein expression and purification.
- Isothermal titration calorimetry to assess binding affinity.
- X-ray crystallography to determine protein-sugar complex structure.
Main Results:
- A second fucose utilization operon was identified in a subset of S. pneumoniae strains, including serotype 3.
- The operon encodes a fucose solute-binding protein (FcsSBP) that specifically binds A and B blood group trisaccharides.
- Structural analysis revealed FcsSBP binds to the reducing end of these trisaccharides, indicating a requirement for soluble blood group antigens.
Conclusions:
- Certain S. pneumoniae strains possess an uncharacterized system for transporting host histo-blood group antigens.
- This finding reveals a new mechanism for S. pneumoniae to acquire nutrients and potentially enhance virulence.
- The study highlights the importance of host glycan structures in bacterial pathogenesis.
Related Concept Videos
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Streptococcal Pharyngitis
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bacterial Meningitis II: Pathophysiology
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

